Enhanced expression of recombinant dystrophin following intramuscular injection of Epstein–Barr virus (EBV)-based mini-chromosome vectors in mdx mice
Open Access
- 1 July 1999
- journal article
- research article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (7) , 1331-1335
- https://doi.org/10.1038/sj.gt.3300944
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Evaluation of Plasmid DNA for in Vivo Gene Therapy: Factors Affecting the Number of Transfected FibersJournal of Pharmaceutical Sciences, 1998
- Dystrophin Expression in Muscles of mdx Mice After Adenovirus-MediatedIn VivoGene TransferHuman Gene Therapy, 1996
- Liposome‐Mediated Gene Transfer into Normal and Dystrophin‐Deficient Mouse MyoblastsJournal of Neurochemistry, 1995
- Generation of βA4 from the amyloid protein precursor and fragments thereofFEBS Letters, 1993
- Quantitation of muscle precursor cell activity in skeletal muscle by Northern analysis of MyoD and myogenin expression: Application to dystrophic (mdx) mouse muscleMolecular and Cellular Neuroscience, 1992
- Cloning muscle isoforms of neural cell adhesion molecule using an episomal shuttle vectorSomatic Cell and Molecular Genetics, 1992
- Fiber regeneration is not persistent in dystrophic (mdx) mouse skeletal muscleDevelopmental Biology, 1991
- Human dystrophin expression in mdx mice after intramuscular injection of DNA constructsNature, 1991
- A Genetic Tool Used to Identify Thioredoxin as a Mediator of a Growth Inhibitory SignalScience, 1991
- Replication of Plasmids Derived from Bovine Papilloma Virus Type 1 and Epstein-Barr Virus in Cells in CultureAnnual Review of Cell Biology, 1987